Rohto Pharmaceutical Co.,Ltd. (TYO:4527)

Rohto Pharmaceutical Revenue

Rohto Pharmaceutical had revenue of 88.81B JPY in the quarter ending December 31, 2025, with 2.30% growth. This brings the company's revenue in the last twelve months to 335.80B, up 13.61% year-over-year. In the fiscal year ending March 31, 2025, Rohto Pharmaceutical had annual revenue of 308.63B with 13.95% growth.

• Revenue (ttm): 335.80B
• Revenue Growth: +13.61%
• P/S Ratio: 1.53
• Revenue / Employee: 36.72M
• Employees: 9,144
• Market Cap: 515.31B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	308.63B	37.79B	13.95%
Mar 31, 2024	270.84B	32.18B	13.48%
Mar 31, 2023	238.66B	39.02B	19.54%
Mar 31, 2022	199.65B	18.36B	10.13%
Mar 31, 2021	181.29B	-7.04B	-3.74%